GLP-1 drugs: what Georgia Medicaid paid

Georgia Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Georgia Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Georgia Medicaid’s payment record shows

In 2026Q1, the product Georgia Medicaid paid for most often was Ozempic®, at 8,018 prescriptions¹⁹ of the 14,981 to 15,134^{1,7,13,19,25,37,43} across all 8 products, or 54 percent of the published count.

Georgia Medicaid itself reimbursed at least $13,040,763 for these products in the quarter, about $871 per prescription. Pharmacies were paid $13,537,150 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,269.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Georgia Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Georgia Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Georgia Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Georgia Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 228¹	2%	$234,258	$266,402	$1,027
tirzepatideMounjaro®	Both932 managed care, 1,768 direct	at least 2,700⁷	18%	$2,717,634	$2,912,418	$1,007
semaglutideWegovy®	Both475 managed care, 18 direct	at least 493¹³	3%	$625,416	$695,258	$1,269
semaglutideOzempic®	Both3,767 managed care, 4,251 direct	at least 8,018¹⁹	54%	$7,760,289	$7,943,644	$968
semaglutideRybelsus®	Both93 managed care, 309 direct	402²⁵	3%	$386,303	$401,082	$961
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	1,259³⁷	8%	$741,378	$741,378	$589
liraglutideliraglutide (generic)	Both706 managed care, 1,158 direct	at least 1,864⁴³	12%	$575,485	$576,967	$309

Georgia Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 1,259 against 1,992. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 8.9 to 9.0 prescriptions per thousand people enrolled in Georgia Medicaid, on an average of 1,687,108 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 22 of the 168 product-quarters it holds a row for here, which is 13 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Georgia Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Georgia Medicaid paid for each product, quarter by quarter

Prescriptions Georgia Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld3 of 3 product codes withheld	at least 48 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$49,493 paid	at least 117 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$121,383 paid	at least 176 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$180,613 paid	at least 228 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$234,258 paid
tirzepatideMounjaro®range 2,332 to 2,511	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	at least 38 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$35,432 paid	at least 253 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$235,451 paid	at least 544 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$527,937 paid	at least 837 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$811,916 paid	at least 933 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$881,199 paid	at least 1,007 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$955,424 paid	at least 877 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$843,995 paid	at least 972 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$919,523 paid	at least 1,216 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$1,157,030 paid	at least 1,364 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$1,310,820 paid	at least 1,683 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$1,622,247 paid	at least 2,097 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$2,047,851 paid	2,332 paid prescriptions in the quarter (2025Q3)⁸Count$2,302,099 paid	2,511 paid prescriptions in the quarter (2025Q4)⁸Count$2,497,172 paid	at least 2,700 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$2,717,634 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	at least 39 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁶At least$49,064 paid	at least 15 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$17,391 paid	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	at least 16 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$20,257 paid	at least 52 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$64,497 paid	at least 109 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$134,727 paid	207 paid prescriptions in the quarter (2025Q1)¹⁴Count$260,112 paid	at least 250 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$313,282 paid	at least 320 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$407,776 paid	at least 412 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$521,489 paid	at least 493 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$625,416 paid
semaglutideOzempic®range 963 to 1,297	963 paid prescriptions in the quarter (2021Q1)²⁴Count$822,637 paid	at least 1,200 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,004,971 paid	1,297 paid prescriptions in the quarter (2021Q3)²⁴Count$1,051,972 paid	at least 1,475 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,194,264 paid	at least 1,818 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,525,784 paid	at least 2,166 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,811,198 paid	at least 2,775 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$2,339,535 paid	at least 2,767 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$2,331,108 paid	at least 3,800 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$3,348,670 paid	at least 4,512 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$3,980,485 paid	at least 4,350 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$3,842,924 paid	at least 3,723 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$3,282,841 paid	at least 4,588 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$4,169,753 paid	at least 5,490 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$5,002,628 paid	at least 6,053 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$5,514,381 paid	at least 6,232 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$5,670,304 paid	at least 6,576 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$6,135,467 paid	at least 7,271 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$6,839,331 paid	at least 7,513 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$7,039,943 paid	at least 7,446 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$6,994,064 paid	at least 8,018 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$7,760,289 paid
semaglutideRybelsus®range 387 to 432, up 15 on the quarter before	at least 84 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$68,776 paid	at least 195 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$159,840 paid	at least 194 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$156,701 paid	at least 226 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$183,144 paid	at least 198 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$168,297 paid	at least 237 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$202,008 paid	at least 339 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$283,730 paid	at least 403 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$338,307 paid	at least 485 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$429,459 paid	at least 614 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$539,191 paid	at least 621 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$549,730 paid	at least 584 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$520,105 paid	at least 522 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$480,514 paid	at least 509 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$463,991 paid	at least 482 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$441,304 paid	at least 445 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$408,263 paid	at least 428 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$401,759 paid	432 paid prescriptions in the quarter (2025Q2)²⁶Count$407,518 paid	at least 404 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$376,849 paid	387 paid prescriptions in the quarter (2025Q4)²⁶Count$358,679 paid	402 paid prescriptions in the quarter (2026Q1)²⁵Count$386,303 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld2 of 2 product codes withheld	at least 20 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld³⁴At least$19,103 paid	at least 17 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld³⁴At least$15,036 paid	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld2 of 2 product codes withheld
liraglutideVictoza®range 625 to 4,796	1,992 paid prescriptions in the quarter (2021Q1)⁴²Count$1,780,219 paid	2,594 paid prescriptions in the quarter (2021Q2)⁴²Count$2,219,682 paid	2,940 paid prescriptions in the quarter (2021Q3)⁴²Count$2,411,378 paid	3,400 paid prescriptions in the quarter (2021Q4)⁴²Count$2,759,384 paid	3,076 paid prescriptions in the quarter (2022Q1)⁴¹Count$2,579,701 paid	3,636 paid prescriptions in the quarter (2022Q2)⁴¹Count$3,081,137 paid	4,169 paid prescriptions in the quarter (2022Q3)⁴¹Count$3,529,942 paid	4,230 paid prescriptions in the quarter (2022Q4)⁴¹Count$3,581,646 paid	4,644 paid prescriptions in the quarter (2023Q1)⁴⁰Count$4,052,118 paid	4,796 paid prescriptions in the quarter (2023Q2)⁴⁰Count$4,248,730 paid	4,574 paid prescriptions in the quarter (2023Q3)⁴⁰Count$4,025,827 paid	4,312 paid prescriptions in the quarter (2023Q4)⁴⁰Count$3,782,947 paid	3,813 paid prescriptions in the quarter (2024Q1)³⁹Count$2,582,074 paid	3,355 paid prescriptions in the quarter (2024Q2)³⁹Count$2,128,649 paid	3,024 paid prescriptions in the quarter (2024Q3)³⁹Count$1,914,441 paid	2,616 paid prescriptions in the quarter (2024Q4)³⁹Count$1,692,485 paid	at least 1,746 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$1,025,463 paid	625 paid prescriptions in the quarter (2025Q2)³⁸Count$386,461 paid	at least 731 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$445,059 paid	at least 945 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$578,564 paid	1,259 paid prescriptions in the quarter (2026Q1)³⁷Count$741,378 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 88 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$53,073 paid	at least 154 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$89,979 paid	at least 619 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$247,042 paid	at least 1,967 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$766,408 paid	at least 2,370 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$839,551 paid	at least 2,347 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$779,134 paid	at least 1,864 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$575,485 paid

What this page cannot tell you

Whether Georgia Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Georgia in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, GA
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "80"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, GA
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "63"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, GA
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, GA
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like ZEPBOUND%, state GA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, GA
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like ZEPBOUND%, state GA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, GA
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like ZEPBOUND%, state GA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, GA
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "416"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, GA
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "381"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, GA
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "196"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, GA
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "264"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, GA
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "109"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, GA
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like MOUNJARO%, state GA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, GA
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "144"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, GA
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "132"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, GA
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, GA
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "26"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, GA
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like WEGOVY%, state GA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, GA
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like WEGOVY%, state GA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, GA
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1576"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, GA
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1456"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, GA
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1627"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, GA
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1410"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, GA
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1095"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, GA
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "619"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, GA
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "146"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, GA
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "146"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, GA
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "143"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, GA
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "209"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, GA
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "158"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, GA
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "77"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, GA
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, GA
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, GA
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, GA
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "20"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, GA
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, GA
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, GA
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "743"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, GA
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "1124"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, GA
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1982"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, GA
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "2334"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, GA
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1976"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, GA
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1457"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, GA
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state GA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "GA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "605"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, GA
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state GA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "767"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, GA
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state GA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "118"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, GA
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state GA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like LIRAGLUTID%, state GA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, GA
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state GA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like LIRAGLUTID%, state GA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, GA
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state GA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "GA", "product_name": "product_name like LIRAGLUTID%, state GA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 39 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 9 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Georgia Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.